The QBE (ASX:QBE) share price jumps to 2021 high on broker upgrades

The QBE Insurance Group Ltd (ASX: QBE) share price surged after a leading broker upgraded the stock while others lifted their valuation on the stock.

| More on:
IAG share price broker upgrade buy

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The QBE Insurance Group Ltd (ASX: QBE) share price surged after a leading broker upgraded the stock while others lifted their valuation on the stock.

The QBE share price soared 6% to its highest level this calendar year at $9.52 during lunch time trade while the S&P/ASX 200 Index (Index:^AXJO) was flat.

In contrast, other insurers like the Suncorp Group Ltd (ASX: SUN) share price and the Insurance Australia Group Ltd (ASX: IAG) share price fell 0.6% each at the time of writing.

QBE share price upgraded to "buy"

A recommendation upgrade by UBS could explain the QBE share price outperformance. The broker upped its rating on the stock to "buy" from "neutral" as it believes the bad news is more than reflected in the current share price post QBE's results.

"While a US$1.5bn loss justifies ~40% share price underperformance over the last 12 months, the vast majority of the provisions taken by QBE (US$655mn for COVID-19 claims) are for currently unreported claims," said the broker.

"Further QBE has provisioned its BI claims to a level that reinsurance protects from any potential developments from here."

UBS also pointed out that the underlying trends in QBE's latest profit announcement was better than originally thought. The broker increased its price target to $10.25 from $9 a share, and it wasn't alone.

QBE price target lifted

The analysts at Citigroup, Goldman Sachs and Macquarie Group Ltd (ASX: MQG) all increased their price targets on QBE, reported the Australian Financial Review.

Citi reiterated its "buy" rating on the stock and increased its target price from $10.40 to $10.95 a share. Goldman Sachs also held its "buy" rating on the QBE share price and raised its price target from $10.24 to $10.73.

Macquarie not only lifted its fair value on QBE to $9.40 from $7.70 a share, but it also upgraded its recommendation on the stock to "neutral" from "underperform" as it believes QBE's outlook has turned more positive.

Stronger operating leverage

It noted that QBE is well placed to benefit from rising insurance premiums. Its profit margins are also increasing from a low base and that means it has better earnings leveraged than its global peers.

"Although no official FY21 guidance was provided, the outlook for margins, premium rates and now FX are all positive and should provide support for the stock until a new group CEO is appointed," the AFR quoted Macquarie as saying.

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »